Terapia con células madre

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSC) in Multiple Sclerosis (SRA) with progressive disease status.

Por NBScience, hace
terapia con células madre